Three trials were published comparing reboxetine against other antidepressants in which reboxetine was just as good, and they were published, but three times as many patients' worth of data was collected which showed that reboxetine was worse than those other treatments, and those trials were not published.
Tre forsøk som sammenlignet reboxetine med andre antidepressiva fant at reboxetine var like god, ble publisert, men data fra tre ganger så mange pasienter, som viste at reboxetine var dårligere enn de andre midlene, ble ikke publisert.